1065PTOPNIVO: A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): First results on behalf of the UNICANCER Head&Neck Group and the GORTEC. (23rd October 2018) - Even, C; Daste, A; Saada-Bouzid, E; Fayette, J; Kaminsky-Forrett, M-C; Zanetta, S; Prevost, A; Lefebvre, G; Borel, C; Cupissol, D; Huguet, F; Delord, J-P; et al.